Browsing: Zunovo

Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha

Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha

Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha

Rafael_Wiedenmeier/iStock Unreleased by way of Getty Images The U.S. FDA has accredited Roche’s (OTCQX:RHHBY) Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) as a twice a yr subcutaneous injection…